REFERENCES
- M. Banciu, R. M. Schiffelers, M. H. Fens, J. M. Metselaar, and G. Storm. (2006). Anti-angiogenic effects of liposomal prednisolone phosphate on B16 melanoma in mice. J. Control. Release 113 (1):1–8.
- B. Clares, and M. M. Medina. (2007). Liposomal triamcinolona acetónido: Influence of composition in performance and stability. Ars Pharmaceutica. 48 (1):19–29.
- P. M. Elias. (1983). Epidermal lipids, barrier function and desquamation. J. Invest. Dermatol. 80:445–495.
- M. A. Hayat. (1989). Principles and techniques of electron microscopy: Biological applications (3rd ed.). London: Macmillan press published.
- S. B. Hoffman, A. R. Yoder, and L. A. Trepanier. (2002). Bioavailability of transdermal methimazole in a pluronic lecithin organogel (PLO) in healthy cats. J. Vet. Pharmacol. Ther. 25 (3):189–193.
- S. K. Jain, R. K. Jain, M. K. Chourasia, A. K. Jain, K. B. Chalasani, V. Soni, and A. Jain. (2005). Design and development of multivesicular liposomal depot delivery system for controlled systemic delivery of acyclovir sodium. AAPS Pharm. Sci. Tech. 6 (1):35–41.
- S. W. Kim, B. Jeong, Y. H. Bae, and D. S. Lee. (1997). Biodegradable block copolymers as injectable drug-delivery system. Nature 388:860–862.
- M. Kunikazu, M. Kazuo, and I. Motoharu. (2000). Spectroscopic investigation of the molecular state of nystatin encapsulated in liposomes. Int. J. Pharm. 15, 201 (1):37–49.
- G. Maierhofer. (1988). Introducción a una nueva tecnología y descripción de técnicas preparativas. Farm. Clin. 5:658–680.
- F. Puisieux. (1985). Microparticulate and nanoparticulate vectors. In P. Buri, F. Puisieux, E. Doelker, and J. P. Benoit. Formes pharmaceutiques nouvelles. Paris: Technique & Documentation (Lavoisier).
- F. Puisieux. (1978). Les liposomes: Classification et obtention. Lab. Pharma Probl. Tech. 281:899–904.
- F. Puisieux, and J. Delattre. (1985). Technological problems posed by the use of liposomes as vectors of medicinal substances, encapsulation, sterilisation, conservation. In Les liposomes, applications thérapeutiquesParis: Technique & Documentation (Lavoisier). 73–113.
- J. J. Torrado, and R. Cadorniga. (1989). Nuevos sistemas de administración de medicamentos. Vectorizacion. CIF 8:242–248.
- C. Valenta, M. Wanka, and J. Heidlas. (2000). Evaluation of novel soya-lecithin formulations for dermal use containing ketoprofen as a model drug. J. Control. Release 63:165–173.
- R. Valljakka-Koskela, M. Kirjavainen, J. Mönkkönen, A. Urtti, and J. Kiesvaara. (1998). Enhancement of percutaneous absorption of naproxen by phospholipids. Int. J. Pharm. 175:225–230.
- J. A. Virtanen, M. Ruonala, M. Vauhkonen, and P. Somerharju. (1995). Lateral organization of liquid-crystalline colesterol-dimyristoylphosphatidylcholine bilayers. Evidence for domains with hexagonal and centered rectangular cholesterol superlattices. Biochemistry 34:11568–11581.
- H. Willian, P. Walde, P. L. Luisi, A. Gazzaniga, and F. Stroppolo. (1992). Lecitin Organogel as matrix for transdermal transport of drugs. J. Pharm. Sc. 81:871–874.